These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10470900)

  • 21. [Functioning of implantable catheters of intraperitoneal chemotherapy].
    de Gramont A; Marpeau L; Demuynck B; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J; Couturier JY; Delfau S
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):381-5. PubMed ID: 1869783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Central venous access in patients with Broviac- and Hickman catheters].
    Rubinstein BE; Susgaard S
    Ugeskr Laeger; 1985 Aug; 147(35):2750-3. PubMed ID: 3934820
    [No Abstract]   [Full Text] [Related]  

  • 23. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 24. Intraperitoneal therapy in the management of patients with ovarian cancer.
    McClay EF; Howell SB
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):915-26. PubMed ID: 1500393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of an implantable system permitting permanent access to the vessels, peritoneum and meninges. Preliminary results in 17 cancer patients].
    Colbert N; Izrael V; Laugier A; Bellaiche A; Renaud J; De Montgolfier S; Bunodiere M; Burstin R; Milleron B
    Presse Med; 1984 Mar; 13(14):887. PubMed ID: 6231622
    [No Abstract]   [Full Text] [Related]  

  • 26. [The use and nursing of intraperitoneal chemotherapy for ovarian cancer].
    Gao SY; Han JH; Li HY
    Zhonghua Hu Li Za Zhi; 1996 Apr; 31(4):211-2. PubMed ID: 8826214
    [No Abstract]   [Full Text] [Related]  

  • 27. [Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy].
    Ge F; Cang J; Xue ZG
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2331-4. PubMed ID: 19087693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spartanburg General Hospital policy book on i.v. therapy administration--Part II.
    NITA; 1986; 9(5):352-84. PubMed ID: 3092150
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hickman catheter for hyperalimentation and treatment of leukemia].
    Rubin M; Waizer A; Dintsman M
    Harefuah; 1982 Nov; 103(9):190-1. PubMed ID: 6820350
    [No Abstract]   [Full Text] [Related]  

  • 30. Peritoneal access for intracavitary chemotherapy.
    Howell SB; Pfeifle CE
    Cancer Drug Deliv; 1986; 3(2):157-61. PubMed ID: 3708538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term venous access using a subcutaneous implantable drug delivery system.
    Soo KC; Davidson TI; Selby P; Westbury G
    Ann R Coll Surg Engl; 1985 Jul; 67(4):263-5. PubMed ID: 4037644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ambulatory chemotherapy by continuous infusion with a portable pump. Ample freedom of movement for the patient].
    Pozzi E; Caravatti M
    Krankenpfl Soins Infirm; 1986 May; 79(5):53-4. PubMed ID: 3635648
    [No Abstract]   [Full Text] [Related]  

  • 33. Early experience with an implantable reservoir for intravenous chemotherapy.
    McIntyre KE; Warneke JA; Malone JM; Bernhard VM
    Ariz Med; 1985 May; 42(5):308-11. PubMed ID: 4015430
    [No Abstract]   [Full Text] [Related]  

  • 34. [Facilitation of long-term chemotherapy using a completely implantable catheter system].
    Kessler W; Schmid L; Hoffmann R; Amgwerd R; Wicky B
    Helv Chir Acta; 1985 Jun; 52(2):253-7. PubMed ID: 4055396
    [No Abstract]   [Full Text] [Related]  

  • 35. [Assessment of intraperitoneal drug distribution during intraperitoneal chemotherapy using saline-injected MR imaging through an implanted catheter-port system].
    Obuchi M; Shimizu A; Fujiwara T; Sugimoto H; Honda M; Kubota H; Yamamoto W; Kinebuchi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1891-5. PubMed ID: 11729482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with a fully implantable delivery system (Port-a-Cath) for the cytostatic treatment of patients with cancer].
    van Groeningen CJ; Meyer S; Dijkhuizen H; Gall H; Pinedo HM
    Ned Tijdschr Geneeskd; 1986 Feb; 130(6):258-61. PubMed ID: 3951628
    [No Abstract]   [Full Text] [Related]  

  • 37. [Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].
    de Graaf PW; ten Bokkel Huinink WW; Aartsen EJ; Mellema MM; Dubbelman R; Hart AA
    Ned Tijdschr Geneeskd; 1987 Feb; 131(8):323-6. PubMed ID: 3561578
    [No Abstract]   [Full Text] [Related]  

  • 38. Pseudo-occlusion of the hepatic artery during hepatic arterial infusion chemotherapy.
    Yamaura H; Inaba Y; Sato Y; Shimamoto H; Nishiofuku H; Arai Y
    J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1835-8. PubMed ID: 17142715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nursing perspectives on intraperitoneal chemotherapy.
    Hoff ST
    J Intraven Nurs; 1991; 14(5):309-14. PubMed ID: 1748914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal of port-catheter system for hepatic arterial infusion chemotherapy implanted with fixed catheter tip method.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Nishimura T
    J Vasc Interv Radiol; 2006 Apr; 17(4):651-6. PubMed ID: 16614148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.